Servier presents its 2019/20 annual results, its R&D strategy and pipeline
All the news from Servier Group
Servier: THE place to work!
L’Institut Servier: “emergency sponsor” of the Neurocovid program
Pascal Lemaire appointed Executive Vice President Finance
Neurological Diseases: Servier and X-Chem Sign Partnership Agreement
SERVIER LOCAL SHARED VALUE: FOR A POSITIVE FOOTPRINT!
Servier to Acquire Agios Pharmaceuticals’ Oncology Business
Colorectal Cancer: Servier and Celsius Therapeutics collaborate for Target Discovery
Creation of Campus Biotech Digital, a platform unique in the world for bioproduction training